Examples of using Granulocytes in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
If intolerance persists after dose adjustment or if granulocytes decrease to< 250/mm3 or ALT/AST rises to>
chronic myeloid leukaemia(CML), a cancer of the white blood cells in which granulocytes(a type of white blood cell)
a cancer of the white blood cells in which granulocytes(a type of white blood cell)
which are synthesised by monocytes/macrophages and granulocytes.
In a double-staining experiment(such as immunoenzymatic staining), the antibody of interest is mixed with an antibody against a structural marker to detect epithelial cell types, lymphocytes, granulocytes, eosinophils, macrophages,
Unknown frequency of occurrence(frequency cannot be estimated from the available data):• Severe allergic reaction resulting in difficulty in breathing and shock• No granulocytes(a type of white blood cell to help you against infection)• Prolonged
Specifically, in the presence of human effector cells including peripheral blood mononuclear cells(PBMC) and granulocytes from normal human donors,
the detection of granulocytes in the urine, as evidenced by the color change of the test strip.
LeukoScan does appear to bind more avidly to activated rather than resting granulocytes.
a type of cancer of the white blood cells where granulocytes(a type of white blood cell)
low counts of blood cells(granulocytes, platelets and red blood cells),
macrophages, granulocytes, NK(natural killer)
are decreased levels of neutrophils or granulocytes and of leucocytes(types of white blood cell),
Besilesomab has no effect on activation of complement, granulocyte function or platelets.
They are the largest type of granulocyte.
However, in vitro granulocyte function tests did not show significant changes when the sulesomab was added.
Prophylactic use of granulocyte colony stimulating factors should be considered in case of repeated delays in cycle administration see section 4.2.
Dose modification due to haematological toxicity Initiation of a cycle For all indications, the patient must be monitored before each dose for platelet and granulocyte counts.
Prophylactic use of granulocyte colony stimulating factors should be considered in case of repeated delays in cycle administration.
platelet and granulocyte transfusions and symptomatic treatment of mucositis.